The paper seeks to assuage the fears and worries over living modified organisms (LMOs). It describes how any research carried out on LMOs as well as any release activity on LMOs for public use in Malaysia is controlled by the Biosafety Act 2007. Stringent risk assessment of the LMO and its product/s is carried out to eradicate or minimize the negative effects of these on animal and human health, and to biological diversity and the environment. In contrast, no such risk assessment is carried out on introduced exotic species, or on the products of other types of technology, with the exception of pharmaceuticals. Examples are given comparing risk assessment on LMOs and exotic species.